Revvity Inc. (NYSE:RVTY) Given Average Rating of “Hold” by Brokerages

Revvity Inc. (NYSE:RVTY) has been assigned an average recommendation of “Hold” from the fourteen research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $112.9167.

A number of research analysts recently commented on the company. Wells Fargo & Company increased their price target on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Evercore increased their price target on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $129.00 price target on Revvity in a report on Tuesday, February 3rd. Bank of America downgraded Revvity from a “buy” rating to a “neutral” rating and set a $110.00 price target for the company. in a report on Monday, December 15th. Finally, Wall Street Zen raised Revvity from a “hold” rating to a “buy” rating in a report on Saturday, February 28th.

Institutional Trading of Revvity

Several institutional investors and hedge funds have recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. raised its stake in Revvity by 26.3% during the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock valued at $751,536,000 after buying an additional 1,784,620 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in Revvity by 127.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after buying an additional 980,142 shares in the last quarter. Norges Bank acquired a new stake in Revvity during the fourth quarter valued at approximately $80,382,000. Morgan Stanley raised its stake in Revvity by 29.6% during the fourth quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock valued at $275,202,000 after buying an additional 650,083 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Revvity by 39.0% during the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock valued at $186,307,000 after buying an additional 596,436 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Trading Up 0.2%

Shares of RVTY opened at $90.57 on Friday. The company has a market capitalization of $10.13 billion, a P/E ratio of 43.54, a P/E/G ratio of 1.92 and a beta of 1.13. Revvity has a one year low of $81.36 and a one year high of $118.30. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68. The stock has a 50-day moving average price of $93.59 and a 200 day moving average price of $96.61.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. The firm had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.Revvity’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Sell-side analysts forecast that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio is presently 13.46%.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.